Controlled Release of Hepatocyte Growth Factor from Gelatin Hydrogels Based on Hydrogel Degradation

This paper investigates the controlled release of hepatocyte growth factor (HGF) by biodegradable gelatin hydrogels and their HGF-induced angiogenic effect. Hydrogels of different degradabilities were prepared through chemical crosslinking gelatin with varied amounts of glutaraldehyde. When the gelatin hydrogels were radioiodinated and subcutaneously implanted into the back of mice, the remaining radioactivity of the hydrogels decreased with time. However, the remaining period became longer when the concentration of glutaraldehyde used for hydrogel preparation increased. Following implantation of gelatin hydrogels incorporating 125I-labeled HGF, the HGF radioactivity retained in the mouse subcutis for longer time periods as the glutaraldehyde concentration becomes higher. The time profile of HGF remaining in every gelatin hydrogel was in good accordance with that of hydrogel degradation, indicating HGF release as a result of hydrogel biodegradation. The gelatin hydrogel incorporating HGF histologically induced angiogenic change around the implanted hydrogel. Gelatin hydrogels incorporating 5 and 10 jig HGF significantly enhanced the number of capillaries newly formed around the implanted site. This was in marked contrast to free HGF of same dose form and HGF-free, empty gelatin hydrogel. The gelatin hydrogel incorporating HGF induced VEGF around the implanted site. In vitro bioassay revealed that HGF molecules interacting with gelatin, still exhibited the biological activity. The interacted HGF would be released from gelatin hydrogels only when they were degraded to generate water-soluble gelatin fragments. It is possible that the HGF associating gelatin fragments of bioactivating, results in induced angiogenic effect.

[1]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[2]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[3]  P. Wingfield,et al.  Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms , 1997, The Journal of Biological Chemistry.

[4]  M. Lyon,et al.  Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. , 1994, The Journal of biological chemistry.

[5]  Y. Ikada,et al.  Biodegradation of hydrogel carrier incorporating fibroblast growth factor. , 1999, Tissue engineering.

[6]  T. Riss,et al.  Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In Vitro , 1992, Journal of cellular physiology.

[7]  J. Rubin,et al.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[9]  C. Colton,et al.  Implantable biohybrid artificial organs. , 1995, Cell transplantation.

[10]  W. Birchmeier,et al.  Evidence for the identy of human scatter factor and human hepatocyte growth factor. , 1991 .

[11]  W. Birchmeier,et al.  Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Ikada,et al.  Protein release from gelatin matrices. , 1998, Advanced drug delivery reviews.

[13]  J. Ranchalis,et al.  Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration , 1994 .

[14]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[15]  J. Ranchalis,et al.  Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. , 1993, Journal of biomaterials science. Polymer edition.

[16]  P. Rudland,et al.  Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells. , 1998, Biochemistry.

[17]  T. Nakamura,et al.  Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[18]  L. Orci,et al.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.

[19]  X. Wu,et al.  A Two-site Model for ApoB Degradation in HepG2 Cells* , 1997, The Journal of Biological Chemistry.

[20]  Y. Ikada,et al.  Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. , 1998, Biomaterials.

[21]  T. Nakamura,et al.  Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. , 1994, The Journal of biological chemistry.

[22]  A. Nishikawa,et al.  Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. , 1995, Journal of biochemistry.

[23]  S. Hirono,et al.  Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture. , 1992, The Journal of biological chemistry.

[24]  K. Matsumoto,et al.  Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. , 1995, Journal of biochemistry.

[25]  K. Takaoka,et al.  Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[26]  Y. Ikada,et al.  Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. , 1999, Biomaterials.

[27]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[29]  K. Matsumoto,et al.  Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. , 1992, Experimental cell research.